Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/01/2007WO2007024944A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists
03/01/2007WO2007024876A2 Methods for treating and monitoring inflammation and redox imbalance in cystic fibrosis
03/01/2007WO2007024860A2 Sulfonamides
03/01/2007WO2007024843A2 Pyrimidinyl-pyrazole inhibitors of aurora kinases
03/01/2007WO2007024814A1 HETEROARYL-SUBSTiTUTED DIAZATRICYCLOALKANES, METHODS FOR ITS PREPARATION AND USE THEREOF
03/01/2007WO2007024810A2 Compositions and methods for the treatment of wounds and the reduction of scar formation
03/01/2007WO2007024789A1 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
03/01/2007WO2007024768A2 Pheromone compositions and methods
03/01/2007WO2007024767A2 Pheromone compositions and methods
03/01/2007WO2007024754A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes
03/01/2007WO2007024745A2 Phosphorus-containing macrocycles
03/01/2007WO2007024741A2 Methods for treatment of thiol-containing compound deficient conditions
03/01/2007WO2007024717A2 Agents for preventing and treating disorders involving modulation of the ryr receptors
03/01/2007WO2007024715A2 Dual variable domain immunoglobin and uses thereof
03/01/2007WO2007024707A2 Tlr agonists
03/01/2007WO2007024705A2 Method of treating depression using a tnf-alpha antibody
03/01/2007WO2007024680A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
03/01/2007WO2007024673A1 Use of ranodine receptor antagonists to trat amotrophic lateral scerosis
03/01/2007WO2007024651A2 Bridged n-bicyclic sulfonamido inhibitors of gamma secretase
03/01/2007WO2007024612A2 8-substituted benzoazepines as toll-like receptor modulators
03/01/2007WO2007024611A2 Sulfonamides of 7 -aminoheptanoic acid derivatives for treating glaucoma
03/01/2007WO2007024593A1 Fused tricyclic mglur1 antagonists as therapeutic agents
03/01/2007WO2007024568A2 Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock
03/01/2007WO2007024501A2 Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore
03/01/2007WO2007024472A2 USE OF PAR- l/PAR- 4 INHIBITORS FOR TREATING OR PREVENTING VASCULAR DISEASES
03/01/2007WO2007024391A2 Light-activated cation channel and uses thereof
03/01/2007WO2007024338A2 3 -ester prodrugs of ethynylestradiol
03/01/2007WO2007024311A1 Acetylcysteine composition and uses therefor
03/01/2007WO2007024183A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma
03/01/2007WO2007024182A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma.
03/01/2007WO2007024108A1 A composition containing timosaponin a-iii for prevention and treatment of type 2 diabetes mellitus
03/01/2007WO2007024029A1 Antiviral agent and viral replication inhibitor
03/01/2007WO2007024008A1 Preventive or therapeutic agent for side effect based on cytotoxicity of anticancer therapy containing apoptosis inhibition activity-enhancing protein fnk or nucleic acid encoding the same
03/01/2007WO2007024004A1 Phenylpyridone derivative
03/01/2007WO2007023935A1 Anti-allergic agent
03/01/2007WO2007023931A1 Composition for prevention of increase in blood alcohol level
03/01/2007WO2007023882A1 Derivative having ppar agonistic activity
03/01/2007WO2007023880A1 Chemokine production inhibitor
03/01/2007WO2007023877A1 Remedy for corneal diseases
03/01/2007WO2007023841A1 Hair growth agent composition
03/01/2007WO2007023791A1 Preparation for external use
03/01/2007WO2007023778A1 Novel anticancer concomitant drug
03/01/2007WO2007023775A1 Therapeutic agent for atrial fibrillation
03/01/2007WO2007023774A1 Agent for amelioration of impaired ophthalmic arterial blood flow
03/01/2007WO2007023768A1 Novel pyridine derivative and pyrimidine derivative (3)
03/01/2007WO2007023766A1 Singlet oxygen generators having silicon-containing substituents
03/01/2007WO2007023754A1 DRUG CONTAINING FBPase INHIBITOR
03/01/2007WO2007023729A1 Sustained-release preparation
03/01/2007WO2007023507A2 Oxazolidinones bearing antimicrobial activity composition and methods of preparation
03/01/2007WO2007023495A2 Method for production of single- and multi-layer microcapsules
03/01/2007WO2007023396A2 Vasoactive kit and composition and uses thereof
03/01/2007WO2007023382A2 Pyrimidine amino pyrazole compounds, potent kinase inhibitors
03/01/2007WO2007023381A1 Methods for the preparation of hcv polymerase inhibitors
03/01/2007WO2007023375A2 Reactive block copolymers
03/01/2007WO2007023370A1 Compositions and methods for treating malaria
03/01/2007WO2007023361A2 Book spread identification arrangement for a board book
03/01/2007WO2007023325A2 Controlled release pharmaceutical composition containing carvedilol
03/01/2007WO2007023307A1 Combinations comprising dmxaa for the treatment of cancer
03/01/2007WO2007023302A1 Combinations comprising dmxaa for the treatment of cancer
03/01/2007WO2007023290A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
03/01/2007WO2007023273A1 Cell migration modulating compounds
03/01/2007WO2007023245A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
03/01/2007WO2007023243A2 Cleavage of antifolate compounds
03/01/2007WO2007023242A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
03/01/2007WO2007023186A1 Pyrazine derivatives and use as pi3k inhibitors
03/01/2007WO2007023182A1 Delta and epsilon crystal forms of imatinib mesylate
03/01/2007WO2007023154A2 Iron (iii) complex compounds for treating iron deficiency in patients with chronic inflammatory intestinal diseases
03/01/2007WO2007023143A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
03/01/2007WO2007023141A1 N-oxides as prodrugs of piperazine & piperidine derivatives
03/01/2007WO2007023135A1 Isotopically substituted benzimidazole derivatives
03/01/2007WO2007023114A1 P38 map kinase inhibitors and methods for using the same
03/01/2007WO2007023110A2 P38 map kinase inhibitors and methods for using the same
03/01/2007WO2007023105A1 FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS
03/01/2007WO2007023073A2 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
03/01/2007WO2007022999A1 Polymer conjugates of k-252a and derivatives thereof
03/01/2007WO2007022991A1 Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain
03/01/2007WO2007022980A1 Use of azabicyclo hexane derivatives
03/01/2007WO2007022956A2 Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent
03/01/2007WO2007022951A1 Use of n-(dibenz (b,f)oxepin-10-ylmethyl)-n-methyl-n-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
03/01/2007WO2007022947A2 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors
03/01/2007WO2007022946A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors
03/01/2007WO2007022944A1 Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier
03/01/2007WO2007022937A1 Pyridazine derivatives with antiinflammatory activity
03/01/2007WO2007022936A1 Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine d3 receptor modulators
03/01/2007WO2007022935A1 Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine d3 receptors
03/01/2007WO2007022933A1 Triazole derivatives as modulators of dopamine d3 receptors
03/01/2007WO2007022924A2 Pharmaceutical compositions with melting point depressant agents and method of making same
03/01/2007WO2007022858A1 3-oxo-indazole-squaric acid derivatives
03/01/2007WO2007022824A1 Use of non-steroidal progesterone receptor modulators
03/01/2007WO2007022734A1 A composition for alleviating a hangover comprising hyaluronic acid and activated carbon
03/01/2007WO2007022651A1 Substituted bicyclo [2.2.2] oct/5-ene compounds and their use as cooling agents
03/01/2007WO2007022642A2 Anti-inflammatory molecules and their uses
03/01/2007WO2007022609A1 Pharmaceutical composition of morphine in ready-to-use injectable solution form and single dosage form of morphine for epidural or intrathecal administration
03/01/2007WO2007022568A1 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
03/01/2007WO2007009094A3 Antisense antibacterial method and compound
03/01/2007WO2007006307A3 Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
03/01/2007WO2007005643A3 Novel aryloxyphenylpropanamines
03/01/2007WO2007003961A3 Gpcr agonists
03/01/2007WO2007003741A3 Polyphenol type compounds, compositions containing same and use thereof for preventing or treating diseases involving abnormal cell proliferation
03/01/2007WO2007002851A3 Thermally-processed cocoa products useful for vascular health improvement
1 ... 3854 3855 3856 3857 3858 3859 3860 3861 3862 3863 3864 3865 3866 3867 3868 3869 3870 3871 3872 3873 3874 ... 7860